Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Ranking of 24 Companies
12 janv. 2023 06h38 HE
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups" report has been added...
Views of 258 Neurology Patient Groups on the Corporate Reputation of Pharma in 2022: Roche Ranked 1st, Novartis Ranked 2nd and Biogen Ranked 3rd
12 janv. 2023 06h28 HE
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups" report has been...
The Views of 300 Asian Patient Groups on the he Corporate Reputation of Pharma, 2021-2022: Overall Gilead Sciences Ranked 1st, Pfizer Ranked 2nd, and ViiV Healthcare Ranked 3rd
12 janv. 2023 06h23 HE
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups" report has been added to ...
Corporate Reputation of Pharma Companies in Spain, 2020 vs 2021: ViiV Healthcare Ranked 1st, Janssen Ranked 2nd, Gilead Sciences Ranked 3rd
09 janv. 2023 08h48 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups" report has been added to...
Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: Focus on Innovation and Treatments, COVID-19, & Pricing and Access to Medicines
09 janv. 2023 08h28 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent...
Patient Perspective of the Corporate Reputation of Pharma in 2021-2022: Focus on Chiesi Farmaceutici, AbbVie, Bayer, Eli Lilly, GSK, Merck, Mylan, Novartis, Pfizer, Roche, Sanofi, Teva Among Others
09 janv. 2023 08h23 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups"...
The Corporate Reputation of Pharma Companies in Canada, 2021-2022: AbbVie, Roche, BMS, Sanofi, Pfizer, Merck, Bayer and Amgen Made the Biggest Rises
09 janv. 2023 08h18 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups" report has been added...
Corporate Reputation of Global Pharma Companies, 2021-2022: How do Pharma Companies Rank Two years into Covid
09 janv. 2023 07h13 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...
Corporate Reputation of Pharma Companies in 2021-2022: The Patient Perspective of 520 Cancer Patient Groups - Pfizer Ranked 1st, Roche/Genentech Ranked 2nd and Novartis was 3rd
05 janv. 2023 05h53 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been added...
Corporate Reputation of the Pharma Companies 2021-2022 Based on 168 HIV/AIDS Patient Groups: AbbVie, BMS, Gilead Sciences, GSK, Janssen, Merck, Mylan, Roche/Genentech, Sandoz, Sanofi, Teva, ViiV
13 déc. 2022 05h28 HE
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups" report has been...